A hemolytic crisis is an acute condition associated with the destruction of red blood cells in the blood, which leads to a sharp decrease in hemoglobin levels and deterioration of oxygen metabolism in the body. This disease can be caused by various factors, including infections, autoimmune disorders, mechanical damage to red blood cells, or toxic effects. Hemolysis can be both acute and chronic, and requires a rapid and accurate diagnostic approach to determine the cause and prescribe adequate treatment. Signs and symptoms of a hemolytic crisis can range from mild malaise to severe anemia with severe hemoglobinuria and possible life-threatening complications.
History of the disease and interesting historical facts
Hemolytic crisis has a long history of study, beginning with discoveries about the nature of red blood cells in the 19th century. Pioneers such as Gregor Mendel and Louis Pasteur contributed significantly to our understanding of genetics and microbial invasion. In the 1920s, scientists began to link hemolysis to serologic reactions while investigating cases of hemolytic anemia in humans after transfusions. Interestingly, many studies in the field of hemolysis have led to the identification of important mechanisms of immune response and pathology. For example, the discovery of the role of antibodies and complement in the pathogenesis of autoimmune hemolytic crisis has opened up new avenues for understanding blood diseases and the development of modern therapeutic approaches.
Epidemiology
According to different studies, the incidence of hemolytic crisis varies depending on the population and ethnic group. About 0.5 - 3 cases per 1000 people per year are registered in the general population. Hemolytic crises are most often observed in patients with existing blood disorders, such as sickle cell anemia or thalassemia. These conditions significantly increase the risk of hemolysis due to various triggers. According to a 2021 study, in some areas with a high incidence of tropical infections, such as malaria, the percentage of hemolytic crisis cases can exceed 10% among those infected.
Genetic predisposition to this disease
Hemolytic crisis has a number of genetic factors that may contribute to its development. The most well-known genes involved are G6PD (glucose-6-phosphate dehydrogenase) and HBB (hemoglobin Beta), mutations of which can lead to red blood cell resistance to oxidative stress. Depending on the type of mutation, the risks and manifestations of the disease may vary. For example, carriers of mutant alleles of G6PD may experience hemolysis when exposed to certain aerosols or drugs such as sulfonamides. In some cases, hereditary variants associated with anemia are also observed, which requires careful examination of family members and genetic counseling.
Risk factors for the development of this disease
Risk factors for hemolytic crisis can be divided into several categories:
- Physical factors: trauma, surgery, mechanical damage to red blood cells.
- Chemical factors: taking certain medications (eg, antibacterial), toxins.
- Infectious factors: viral and bacterial infections such as malaria or sepsis.
- Autoimmune diseases: such as systemic lupus erythematosus or Guillain-Barré syndrome.
- Hereditary predisposition: presence of blood diseases in the family.
These factors can act either individually or in combination to increase the risk of hemolytic crisis.
Diagnosis of this disease
Diagnosis of hemolytic crisis includes several key stages:
- Main symptoms: fatigue, pallor, jaundice, acute renal failure.
- Laboratory tests: complete blood count, hemoglobin, bilirubin, lacto- and de-lactate dehydrogenase (LDH) data.
- Radiological examinations: ultrasound examination of abdominal organs to identify complications.
- Other types of diagnostics: testing for the action of certain antibodies, assessing the level of enzymes in the plasma.
- Differential diagnosis: exclusion of other forms of anemia, such as aplastic or iron deficiency anemia.
Correct and prompt completion of all these steps is critical to selecting the appropriate treatment.
Treatment
Treatment of hemolytic crisis depends on its cause and symptoms:
- General treatment: neutralization of triggers, limitation of active physical activity.
- Pharmacological treatment: use of corticosteroids to reduce the autoimmune response, prescription of immunosuppressants.
- Surgical treatment: in case it is necessary to remove splenomas if it is associated with excess destruction of red blood cells.
- Other treatments include blood or blood product transfusions to reduce anemia, plasmapheresis.
Complex treatment requires regular assessment of the patient's condition and may change depending on the body's response to therapy.
List of medications used to treat this disease
Some of the main medications used to treat hemolytic crisis include:
- Corticosteroids (eg, prednisolone)
- Immunosuppressants (eg, azathioprine).
- Preparations containing erythropoietin.
- Antibiotics for the treatment of concomitant infections.
- Medicines for metabolic correction.
These drugs should only be used under the supervision of a specialist, as they can have serious side effects.
Disease monitoring
Monitoring of hemolytic crisis involves regular assessment of hemoglobin, bilirubin, and other blood parameters. Prognosis may vary depending on the cause of hemolysis and the adequacy of treatment. Some patients may develop complications, such as gastrointestinal or renal dysfunction, requiring more intensive monitoring and treatment. With early diagnosis and appropriate treatment, many patients can achieve remission.
Age-related features of the disease
Hemolytic crisis can manifest itself differently depending on the age group. Newborns and infants have a high risk of hemolytic disease due to incompatibility of blood with the mother (e.g. Rh incompatibility). In adults, cases are more often associated with systemic lupus erythematosus or certain medications. In the elderly, hemolysis can be a secondary effect of other chronic diseases such as diabetes or cardiovascular disease.
Questions and Answers
- What are the main symptoms of hemolytic crisis? The main symptoms include fatigue, pallor, jaundice, acute renal failure.
- Can a hemolytic crisis occur without previous diseases? Yes, it can occur in healthy patients due to acute infections or acute exposure to toxins.
- How is the disease diagnosed? Diagnostik includes a complete blood count, laboratory tests for carbohydrate and protein components, and a clinical examination.
- What medications help with hemolytic crisis? Key medications include corticosteroids, immunosuppressants, and blood transfusions.
- What is the risk of complications in patients with hemolytic crisis? The risk of complications depends on the patient's health and the treatment chosen, but can be 10-20% without adequate monitoring.
Dr. Oleg Korzhikov advises: “If any of the symptoms of a hemolytic crisis develop, especially if they occur against the background of a previous illness or taking new medications, it is necessary to immediately seek medical help. Timely diagnosis and treatment are key to reducing the risk of this condition. In addition, preventing infectious diseases and careful health monitoring in risk groups can be very effective measures to reduce the frequency of hemolytic crises.”
